About Cardiac Dimensions
Cardiac Dimensions is a Healthcare company based in Kirkland (United States) founded in 2001. Invasive cardiac implants for heart failure treatment are developed. Cardiac Dimensions has raised $260.8 million across 18 funding rounds from investors including Hostplus, EQT and Oxford Finance. Cardiac Dimensions offers products and services including Carillon Mitral Contour System. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is CARDIAC DIMENSIONS INC. Its competitors include Shockwave Medical, JenaValve Technology and Capstan Medical; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2001, Cardiac Dimensions operates in the medical device sector, focusing on treatments for heart failure and mitral regurgitation. Invasive implants, such as the Carillon Mitral Contour System, are designed for non-surgical placement via catheter through the jugular vein to reshape the mitral valve. The company is based in Kirkland, United States, where development and innovation in cardiac therapies are conducted.
- Headquarters Kirkland, United States
- SectorsHealthcare
- Website cardiacdimensions.com
- Social LinkedIn Instagram YouTube
- Legal Name Cardiac Dimensions Inc.
- Total Equity Funding$260.8M (USD)
in 18 rounds
- Latest Funding Round$53M (USD), Series E
Mar 2025
- InvestorsHostplus
& 18 more
Products & Services of Cardiac Dimensions
Cardiac Dimensions offers a comprehensive portfolio of products and services, including Carillon Mitral Contour System.
Treats functional mitral regurgitation in heart failure patients via minimally invasive procedure.
Apps and channels of Cardiac Dimensions
its YouTube channel Cardiac Dimensions has 469 subscribers and 29 videos.
Videos from Cardiac Dimensions
The most watched videos on Cardiac Dimensions's YouTube channel, Cardiac Dimensions (469 subscribers). Click a video to play it here.
More on Cardiac Dimensions.
Funding Insights of Cardiac Dimensions
Cardiac Dimensions has successfully raised a total of $260.8M across 18 strategic funding rounds. The most recent funding activity was a Series E round of $53 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $260.8M
- Total Rounds 18
- Last Round Series E — $53M
- First Round $12M
(Jun 2002)
- Investors Count 19
Latest 10 of 18 funding rounds of Cardiac Dimensions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $53M | Series E | – | Ally Bridge Group | |
| Jan 2023 | $35M | Series D | – | Horizon 3 Healthcare | |
| Sep 2020 | $17.5M | Series C | – | Life Sciences Partners | |
| Apr 2018 | $12M | Debt – Venture | – | – | |
| Apr 2018 | $27M | Series C | – | Hostplus | |
| Mar 2015 | $15.2M | Series C | – | Life Sciences Partners, Aperture Venture Partners | |
| Oct 2014 | $8.5M | Series C | – | Arboretum Ventures | |
| Apr 2014 | $20M | Series C | – | M.H. Carnegie & Co, Lumira Ventures | – |
| Dec 2013 | $1.2M | Series C | – | – | – |
| Oct 2013 | $555,000 | Series C | – | – | – |
19 investors in total: 19 institutional.
Investors in Cardiac Dimensions
Cardiac Dimensions has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include Hostplus, EQT and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and hedge fund investments in healthcare are managed. | ally-bridge.com | Hong Kong, China | ||
Private equity investments are directed toward multiple sectors. | claret-capital.com | London, United Kingdom | ||
Investment platforms are managed by M.H. Carnegie & Co. | mhcarnegie.com | Moore Park, Australia | ||
Healthcare investments are managed by H3 Healthcare in Australia. | h3healthcare.com.au | Melbourne, Australia | ||
Lumira Ventures is engaged in life sciences venture capital investment. | lumiraventures.com | Toronto, Canada | ||
Healthcare venture capital investments are made by Arboretum Ventures. | arboretumvc.com | Ann Arbor, United States | ||
EQT is recognized as a global investment organization focused on value creation. | 1994 | eqtgroup.com | Stockholm, Sweden | |
A healthcare-focused investment firm supporting innovative company growth. | aperturevp.com | |||
Private equity investments in life sciences businesses are managed. | 1998 | lspvc.com | Amsterdam, Netherlands | |
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States |
Investor details for Cardiac Dimensions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cardiac Dimensions
29 people are tracked at Cardiac Dimensions (7 in leadership, 3 in board & advisors, 19 in team).
| Name | Role | Group |
|---|---|---|
Steven Goldberg | Chief Medical Officer | Leadership |
Bob Calcote | Vice President, Operations & Compliance | Leadership |
Carmelo Mastrandrea | Vice President, Sales | Leadership |
Rick Wypych | President & Chief Executive Officer | Leadership |
Robert Calcote | Vice President, Operations and Compliance | Leadership |
Tim Johnson | Director Of R&d | Leadership |
Henry Hauser | Vice President, Clinical Affairs | Leadership |
Mark Carnegie | Board Member | Board & advisors |
Daniel Hetu | Board Member | Board & advisors |
Trevor Moody | Director Board Of Directors | Board & advisors |
Matthew Winter | Manufacturing Engineering Manager, Interim | Team |
Karsten Wohlmacher | Regional Manager & Clinical Specialist | Team |
Travis Shepperd | Manager of Inventory & Logistics | Team |
Mitchell Witkowski | Principle R&d Engineer | Team |
Rita Casimiro | Advanced Clinical Specialist & Clinical Proctor | Team |
Bob Conta | Vice Pres. R.&d. | Team |
Eliane Porchet | Regional Manager Switzerland | Team |
Florian Nassr | Regional Manager | Team |
Jeff Edfast | Manufacturing Engineer | Team |
Peter Adam | Principle R&D Engineer | Team |
9 more people are available in the full profile.
Complete people profiles for Cardiac Dimensions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cardiac Dimensions
3 dated milestones of Cardiac Dimensions across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Cardiac Dimensions is founded.
- Funding First funding round of $12.0M.
- Funding Latest funding round, Series E, of $53.0M.
Competitors of Cardiac Dimensions
Cardiac Dimensions has 3 listed competitors in our database, 3 of them funded. They include Shockwave Medical, JenaValve Technology and Capstan Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| shockwavemedical.com | 2009 | Santa Clara, United States | $147.5M | 1,394 | Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed. | |
| jenavalve.com | 2006 | Irvine, United States | $363.7M | 198 | Pericardial transcatheter aortic valve replacement systems are provided. | |
| capstanmedical.com | 2020 | Santa Cruz, United States | $141.4M | Medical devices for structural heart disease treatment are developed. |
Detailed competitors of Cardiac Dimensions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cardiac Dimensions
The website of Cardiac Dimensions (cardiacdimensions.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▲ 100.1% vs previous month
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Cardiac Dimensions (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cardiac Dimensions
Complete news archive for Cardiac Dimensions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cardiac Dimensions
Cardiac Dimensions was founded in 2001 and raised its 1st funding round 1 year after it was founded.
Cardiac Dimensions is headquartered in Kirkland, United States. It is registered at Kirkland, Washington, United States.
Cardiac Dimensions is a funded company, having raised a total of $260.8M across 18 funding rounds to date. The company's 1st funding round was a Series C of $555K, raised on Jun 2002.
Founded in 2001, Cardiac Dimensions operates in the medical device sector, focusing on treatments for heart failure and mitral regurgitation. Invasive implants, such as the Carillon Mitral Contour System, are designed for non-surgical placement via catheter through the jugular vein to reshape the mitral valve. The company is based in Kirkland, United States, where development and innovation in cardiac therapies are conducted.
Cardiac Dimensions's top competitors include Shockwave Medical, JenaValve Technology and Capstan Medical.
Cardiac Dimensions offers Carillon Mitral Contour System.
Cardiac Dimensions has 19 investors. Key investors include Hostplus, EQT, Oxford Finance, Frazier Healthcare Partners, and Life Sciences Partners.
Cardiac Dimensions operates through Cardiac Dimensions Inc..